Sodium salicylate in moderate or large dosage has been shown to decrease glycogen concentration in the liver of fed and starved mice 2 hr. after injection (Sproull, 1954) and in rats 4-7 hr. after administration (Lutwak-Marm, 1942; Smith, Meade & Bornstein, 1952; Feeney, Carl6 & Smith, 1955) . Lutwak-Mann (1942) studied the effect of large doses of certain substituted benzoic acids on ratliver glycogen, and found that although acetylsalicylate, benzoate, anthranilate, o-cresotate (2-hydroxy-3-methylbenzoate) and m-hydroxybenzoate all caused some decrease in liver-glycogen concentration 7 hr. after injection, only acetylsalicylate and o-cresotate showed an effect similar to salicylate; with o-cresotate (0.6 mg./g.) there was virtually no glycogen present over the 24 hr. period of the experiment. Feeney et al. (1955) reported that salicylate, acetylsalicylate and m-hydroxybenzoate all decreased rat-liver-glycogen concentration significantly although the reduction after m-hydroxybenzoate was not as pronounced as that obtained with salicylate.
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The present investigation was to determine which of ten substituted benzoic acids related to Aalicylic acid and of therapeutic interest in the treatment of rheumatic fever decreased-the liverglycogen concentration of fed mice 2 hr. after injection.
METHODS
Swiss albino mice, were used in all experiments and the drugs were all given by intraperitoneal injection. The mice were killed by cervical dislocation 2 hr. after injection and 300-400 mg. of liver was removed for the estimation of liver glycogen. Glycogen was separated -and hydrolysed by the Good, Kramer & Somogyi (1933) modification of Pfluiger's method, and finally it was estimated as glucose by eerie sulphate titration (Miller & van Slyke, 1936) . The glycogen concentration was expressed as mg./g. wet wt. of liver.
In the first experiments mice (age 3-5 months) were dealt with in batches of nine of the same sex per day, and were allowed food and water freely until the start of the experiment. Three animals from each batch were killed without injection at zero time, another three were injected with 0*2 ml. of 0 9 % NaCl soln. and the remaining three received the same volume of the test drug, these two'lastnamed trios being killed 2 hr. after 'injection. Four such batches, two for each sex, were used for each drug, which was given as a solution of the sodium salt (pH 7.0-9-0). Dose-respon8e curve for salicylic acid. Mice (age 2-4 months) of weight range 30-50 g. were allowed food and water until the start of the experiment. The mice were treated in batches of seven mice of the same weight and sex; each of six mice received a dose of 2, 4,'6, 8, 10 or 12 mg. of salicylic acid as a solution of the sodium salt (pH 6.0-8.0) and the seventh mouse reeeived 0.05 ml. of 0 9 % NaCl soln. The order in which the doses were given was determined from a table of random'numbers. Sixteen estimates (eight males, eight females)-of AG, i.e. the differ-ence in liver glycogen between the corresponding control and treated mice, were determined for each dose.
Parallel-line assay. The compounds used, each in four doses, were salicylic acid, o-cresotic acid, m-cresotic acid (2-hydroxy-4-methylbenzoic acid), p-cresotic acid (2-hydroxy-5-methylbenzoic acid) and 3-phenylsalicylic acid, made up as solutions of their sodium salts. Mice (age 3-5 months) of weight range 30-50 g. were treated in batches of 12 of the same sex. Two mice were given 0 05 ml. of 0 9 % NaCl soln.; each of the other ten received one of four doses of each of the five drugs. The four doses of the five drugs were chosen so that the doses of each drug were evenly spaced on a logarithmic scale and the range of expected responses to the drugs was approximately the same. The order of observations with respect to drug and dose was randomized. Twelve estimates of AG, i.e. the difference in liver-glycogen concentration between the mean of the two controls and the treated mice within the same batch, were made for each dose and drug for both sexes. Sixteen hours before the start of the experiment the drinking water was replaced by 5 % glucose solution; food was allowed until the start of the experiment. Table 1 shows the effect of ten compounds on the liver-glycogen concentration of normal, fed mice. The compounds which decreased the liver-glycogen concentration were salicylic acid, o-, m-and pcresotic acid and 3-phenylsalicylic acid. The mean liver-glycogen concentration of 100 control mice killed 2 hr. after injection of 09°% NaCl soln. was 25-3 + 1-5 mg./g. (a 14.7). The liver-glycogenconcentrations were consistent with a normal distribution and a quality-control chart ofbatchmeans confirmed that the experiment was under statistical control.
RESULTS
Lutwak-Mann (1942) took as her controls the liver-glycogen concentration of those rats killed at zero time. The present experiments show that, with mice, this practice would lead to erroneous conclusions. The mean glycogen concentration of 90 mice killed at zero time was 41-0 mg./g. This mean was significantly higher than the value 2 hr. after injection of 0-9 % NaCl soln. (t test, P < 0.001).
The liver-glycogen concentrations of 90 mice killed at zero time also showed an approximately normal distribution and the quality-control chart for these results was acceptable. Do8e-reponse curve for 8alicyl?c acid. The log dose-response curve for the effect of salicylic acid on mouse-liver-glycogen concentration ( Fig. 1) showed an approximately linear relationship between log dose and AG. Homogeneity of variance was confirmed by Bartlett's test (1937) , P > 0.50. Table 2 gives the analysis of variance of AG over the dose range used, which shows that there was no significant component of variance due to deviations from the linear regression found when the dose was transformed into a logarithmic scale. The mean liver-glycogen concentration of the 16 control mice was 27 6 + 2-8 mg./g. (a 11.3).
Parallel-line a88ay. The form of the doseresponse curve for salicylic acid suggested that the potencies of the other glycogenolytic drugs relative to salicylic acid could be determined by a comparative parallel-line assay.
Before proceeding to this experiment, attempts were made to reduce the variance of the glycogen concentration. Sproull (1954) noted that the variance of male mice was greater than that of females. In the present investigation the coefficient of variation for the control males was 64 %; for the females it was 45 %. Replacing the drinking water by 5 % glucose solution 16 hr. before the start of the experiment slightly reduced these coefficients to male 48 %, female 23 %, through increases in the mean liver-glycogen concentrations rather than through a reduction in variance. The mean glycogen concentration of 84 male control mice killed 2 hr. after the injection of 0 9 % NaCl soln. was 24-9 + 1-7 mg./g. (a 15-9), and for -86 female mice it was 29-9 + 1-4 mg./g. (a 13.4). The mean for 50 control male mice given 5 % glucose to drink 16 hr. before the start of the experiment was 33-3±2-6 (a 16-0), and for 50 female mice was 47-5 ± 1-5 mg./g. (a 10-8). M. M. ANDREWS For the mice given 5 % glucose to drink there was a significant difference in variance between the males and females (F ratio 2-19, P < 001). The mean of the females was also significantly higher than that of the males (t test, P < 0001). For both sexes the glycogen concentrations showed approximately normal distributions (Fig. 2B) , and quality-control charts of means of three consecutive estimates of liver-glycogen concentration 2 hr. after injection with 0-9 % NaCl soln. showed that the experiments were under statistical control. Since there was a significant difference in variance between the sexes, the male and female mice were dealt with separately. For both' sexes the high variance of the results masked any relationship between dose and response for m-and p-cresotic acid. Salicylic acid, o-cresotic acid and 3-phenylsalicylic acid all showed an approximately linear relationship between log dose and AG over the dose ranges used (Fig. 3) . Table 3 gives the doses used and the regression equations for both sexes.
The requirements for a valid comparative parallel-line assay are linearity and parallelism. Homogeniety of variance was confirmed for both sexes by Bartlett's test (females P > 0-50, males P > 0 10); analyses of variance then showed that there was no significant deviation from log-linear regression, nor was there a significant component of variance due to differences in slope of the regression lines (Table 4) .
The molar potency ratios of o-cresotic acid and 3-phenylsalicylic acid as glycogenolytic agents relative to salicylic acid were calculated and are shown with their 95 % fiducial limits, obtained from Fieller's (1940) theorem, in Table 5 . For both sexes, 3-phenylsalicylic acid was significantly more potent than salicylic acid; the potency ratios were 4-79 in the females and 2-68 in the males. Although the potency ratios for o-cresotic acid were also greater than 1 in both sexes only the females GLYCOGENOLYSIS FROM SOME SALICYLIC ACIDS Table 3 . Regression equations, for both sexes, of AG upon log do8e, and dose range for the three compoUnd8 used in the parallel-line assay Y = AG, i.e. difference in liver-glycogen concentration between the mean of the two controls and the treated mice from the same batch (mg./g.); X = log dose (mg.). (t2s2)f(b2ESXX) where 82 is the variance and Sxx is S(x-xi)2 (Finney, 1952 liver-glycogen method, experienced the same diffiDose (mg.) culties, and Nissim (1953) stated that the liverse of the drug and AG (differ-glycogen concentration of mice was sensitive to the two control mice and the changes in temperature, feeding, environment and e batch) for (a) females and purity of strain. Barnes (1953) reported the same ad on a logarithmic scale and variation in rats and reduced it slightly by sub- (1-22-2*84) (0-89-2-48) by the extra glucose in the water (Fig. 2) (1953) reported that liver-glycogen concentrations of control mice did not follow a normal distribution. In the present investigation liverglycogen concentrations of both sexes were consistent with normal distributions ( Fig. 2A and B) , and quality-control charts confirrned that the experiments were under statistical control, whether or not the animals received a supplement of 5 % glucose in their drinking water.
Compound
The drugs that, in 10 mg. doses, did not alter the concentration of glycogen in mouse liver were mand p-hydroxybenzoic acid, gentisic acid, yresorcylic acid and salicylamide. Lutwak-Mann (1942) , using higher doses in rats (0-8 mg./g.), claimed that over a 24 hr. period m-hydroxybenzoate caused a gradual decrease in the liverglycogen concentration; she did not examine the other compounds.
The only compounds which decreased the liverglycogen concentration of fed mice were salicylic acid, o-, m-and p-cresotic acid and 3-phenylsalicylic acid. All but the 3-phenylsalicylic acid have been used therapeutically in the treatment of rheumatic fever (May, 1909; Stockman, 1912) .
The dose-response curve for salicylic acid was linear when AG was plotted against dose transformed into a logarithmic scale. Inspection of the results indicated that on the days when the control values were low the treated mice also tended to give lower results; AG was therefore used rather than the actual glycogen concentration. The variance of AG within each dose and drug was also slightly lower than the variance of the glycogen concentration, suggesting that use of the difference between the control and treated mice within the same batch reduced some of the variation attributable to environmental conditions. A standard comparative parallel-line assay was used for the determination of potency, Both 3-phenylsalicylic acid and o-cresotic acid were more powerful glycogenolytic agents than salicylic acid when administered in single doses intraperitoneally to mice. 3-Phenylsalicylic acid was apparently the more powerful (Table 5 ). The fiducial limits showed that the differences were significant at the 95 % level for both drugs in the females but only for 3-phenylsalicylic acid in the males. For both drugs this difference in potency between the sexes could not be definitely established from the present assay and is probably largely fortuitous.
One of the many biological properties of salicylic acid is its ability to increase the rate of oxygen consumption in man (Barbour & Devenis, 1919) and animal (Singer, 1901; Reid, 1957) . o-, m-and p-Cresotic acid and 3-phenylsalicylic acid have a similar stimulant action in the rat; the relative molar potency ratios of these drugs compared with salicylic acid were: o-cresotic acid 2-6, m-cresotic acid 1-8, p-cresotic acid 1-9 (Andrews, 1958 ) and 3-phenylsalicylic acid 7-5 (M. M. Andrews, unpublished result) . In the present series only those compounds which increased the rate of oxygen consumption of rats possessed glycogenolytic activity. The present results do not exclude a relationship between glycogenolytic and metabolic activity. In mice 3-phenylsalicylic acid shows the greatest glycogenolytic effect, followed by ocresotic acid, m-and p-cresotic acid and salicylic acid. This ranking also applies to the effects of these compounds as metabolic stimulants in rats (Andrews, 1958) . The molar potency ratios of ocresotic acid and 3-phenylsalicylic acid as glycogenolytic agents relative to salicylic acid were of the same order as those for metabolic activity. Other metabolic stimulants have also been found to lower the liver-glycogen concentration. Barnes (1953) found that single doses of dinitro-o-cresol, a powerful metabolic stimulant, decreased the liver-glycogen concentration of rats. Thyroid hormones, which also increase metabolic rate, possess glycogenolytic properties in animals (Cramer & Krause, 1913; Houssay, 1946) . Cramer & McCall (1917) suggested that the 'increased oxidative processes in the cell' after the administration of thyroid hormones were due to the glycogenolytic action of the hormones, and Sutherland (1951) has supported the suggestion of Cori (1931) that at least part of the increased oxygen consumption caused by adrenaline may be the indirect result of glycogenolysis. This hypothesis seems unlikely in the present case since Meade (1954) and Andrews (1958) demonstrated a significant increase in the rate of oxygen consumption of rats within 1 hr. of injecting salicylic acid, whereas the fall in liver-glycogen concentration in rats became apparent about 4 hr. after injection (Lutwak-Mann, 1942 
